{"data":[{"accessionNo":"0001104659-26-114392","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":"88025U109","securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2026-09-30","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":6272998,"percentOfClass":5.22,"filedAt":"2026-10-07"},{"accessionNo":"0001104659-26-114392","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":"88025U109","securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2026-09-30","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":6272998,"percentOfClass":5.22,"filedAt":"2026-10-07"},{"accessionNo":"0000080255-26-000600","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001770787","issuerName":"10X GENOMICS INC-CLASS A","ticker":"TXG","cusip":"88025U109","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":14044020,"percentOfClass":11.7,"filedAt":"2026-09-08"},{"accessionNo":"0001104659-26-096964","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":"88025U109","securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":10003058,"percentOfClass":8.56,"filedAt":"2026-08-14"},{"accessionNo":"0001104659-26-096964","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":"88025U109","securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":10003058,"percentOfClass":8.56,"filedAt":"2026-08-14"},{"accessionNo":"0002100119-26-000076","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001770787","issuerName":"10X Genomics Inc","ticker":"TXG","cusip":"88025U109","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":6166597,"percentOfClass":5.24,"filedAt":"2026-04-29"},{"accessionNo":"0002100121-26-000070","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001770787","issuerName":"10X Genomics Inc","ticker":"TXG","cusip":"88025U109","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Portfolio Management","reportingCik":null,"personType":"IA","sharesOwned":6981683,"percentOfClass":5.93,"filedAt":"2026-04-28"},{"accessionNo":"0000102909-26-000354","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001770787","issuerName":"10X Genomics Inc","ticker":"TXG","cusip":"88025U109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-25"},{"accessionNo":"0000102909-26-000351","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001770787","issuerName":"10X Genomics Inc","ticker":"TXG","cusip":"88025U109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-24"},{"accessionNo":"0000315066-26-000666","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":18543561.62,"percentOfClass":15.6,"filedAt":"2026-03-06"},{"accessionNo":"0000315066-26-000666","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2026-02-27","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":18543561.62,"percentOfClass":15.6,"filedAt":"2026-03-06"},{"accessionNo":"0000315066-26-000056","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":12696254.11,"percentOfClass":10.8,"filedAt":"2026-01-08"},{"accessionNo":"0000315066-26-000056","formType":"SCHEDULE 13G/A","amendmentNo":13,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":12696254.11,"percentOfClass":10.8,"filedAt":"2026-01-08"},{"accessionNo":"0001140361-25-041820","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"Class A common stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Amova Asset Management Americas, Inc.","reportingCik":null,"personType":"IA","sharesOwned":5376883,"percentOfClass":4.7,"filedAt":"2025-11-13"},{"accessionNo":"0000315066-25-002657","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9283772.62,"percentOfClass":8.1,"filedAt":"2025-11-05"},{"accessionNo":"0000315066-25-002657","formType":"SCHEDULE 13G/A","amendmentNo":12,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"CLASS A COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9283772.62,"percentOfClass":8.1,"filedAt":"2025-11-05"},{"accessionNo":"0001104659-25-106343","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"ARK Investment Management LLC","reportingCik":null,"personType":"IA","sharesOwned":11887396,"percentOfClass":10.39,"filedAt":"2025-11-04"},{"accessionNo":"0001104659-25-106343","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"Class A Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Catherine D. Wood","reportingCik":null,"personType":"HC,IN","sharesOwned":11887396,"percentOfClass":10.39,"filedAt":"2025-11-04"},{"accessionNo":"0000102909-25-000030","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001770787","issuerName":"10X Genomics Inc","ticker":"TXG","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":13274332,"percentOfClass":11.6,"filedAt":"2025-10-30"},{"accessionNo":"0001214659-25-015319","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"Class A common stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Sumitomo Mitsui Trust Group, Inc.","reportingCik":null,"personType":"HC,FI","sharesOwned":5381219,"percentOfClass":4.7,"filedAt":"2025-10-27"},{"accessionNo":"0001214659-25-015319","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001770787","issuerName":"10x Genomics, Inc.","ticker":"TXG","cusip":null,"securityClass":"Class A common stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Amova Asset Management Co., Ltd.","reportingCik":null,"personType":"IA,HC,FI","sharesOwned":5376883,"percentOfClass":4.7,"filedAt":"2025-10-27"}],"updatedAt":"2026-10-14T17:24:36.406Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}